In 1981, Hybritech issued its Initial Public Offering and raised $12 million, and $33 million in a secondary offering in 1982.

Hybritech was founded by cancer researcher Ivor Royston and lab technician Howard Birndorf of the University of California, San Diego, becoming San Diego’s first biotechnology company.The company was acquired by Eli Lilly in 1986.